# Merz North America, Inc. clinical trials: 53

ClinicalTrials.gov lists 53 trials with Merz North America, Inc. as lead sponsor, 1 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Merz North America, Inc.: 53 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/merz-north-america-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 53
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 53, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 5, 2026 | NCT07856797 | A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds | Merz North America, Inc. | Not applicable | Recruiting | Nasolabial Folds | 163 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856797) |
| May 29, 2026 | NCT07614997 | Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck | Merz North America, Inc. | Not applicable | Active not recruiting | Cutis Laxa | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614997) |
| August 14, 2025 | NCT07122193 | A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States | Merz North America, Inc. | Phase 3 | Active not recruiting | Neuromuscular Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs, Acetylcholine Release... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07122193) |
| July 25, 2025 | NCT07086248 | A Study to Determine if RADIESSE® Dilute Treatment in Décolleté of Adult Women Affects Radiographic Imaging Assessments | Merz North America, Inc. | Not applicable | Active not recruiting | Décolleté Wrinkles | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07086248) |
| October 23, 2023 | NCT06093815 | Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products | Merz North America, Inc. | Not applicable | Completed | Injection Site Reaction | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06093815) |
| March 24, 2023 | NCT05784363 | A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face | Merz North America, Inc. | Phase 1 | Completed | Enlarged Pores, Sebum Production | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05784363) |
| March 17, 2023 | NCT05773066 | A Study of Belotero® Intense Lidocaine for Lip Augmentation | Merz North America, Inc. | Not applicable | Completed | Lip Augmentation | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05773066) |
| February 3, 2022 | NCT05222607 | Longitudinal Evaluation and Real-world Evidence of NT201 | Merz North America, Inc. | Observational | Terminated | Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05222607) |
| December 20, 2021 | NCT05163353 | Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles | Merz North America, Inc. | Not applicable | Completed | Décolleté Wrinkles | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05163353) |
| October 5, 2021 | NCT05067504 | Effectiveness and Safety of the Octave System for Lifting the Eyebrow and Improving the Appearance of the Face and Neck | Merz North America, Inc. | Not applicable | Completed | Eyebrow Lift, Improved Appearance of the Face and Neck | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05067504) |
| May 14, 2021 | NCT04886232 | A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido... | Merz North America, Inc. | Not applicable | Completed | Cheek Volume Augmentation | 202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04886232) |
| March 12, 2021 | NCT04795622 | Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum | Merz North America, Inc. | Not applicable | Completed | Improvement in Skin Laxity of the Lower Face and Submentum | 201 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04795622) |
| December 23, 2020 | NCT04681352 | A Study of Octave System for Improving Lines and Wrinkles of the Décolleté | Merz North America, Inc. | Not applicable | Completed | Décolleté Wrinkles | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04681352) |
| December 1, 2020 | NCT04647721 | Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds | Merz North America, Inc. | Not applicable | Completed | Correction of Moderate to Severe Nasolabial Folds (NLFs) | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04647721) |
| November 9, 2020 | NCT04622254 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows... | Merz North America, Inc. | Phase 3 | Completed | Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) | 368 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04622254) |
| October 20, 2020 | NCT04594239 | Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow | Merz North America, Inc. | Not applicable | Completed | Volume Loss in the Infraorbital Hollow Area | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04594239) |
| October 20, 2020 | NCT04594213 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral... | Merz North America, Inc. | Phase 3 | Completed | Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) | 362 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04594213) |
| December 17, 2018 | NCT03777917 | A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow | Merz North America, Inc. | Not applicable | Completed | Correction of Volume Loss in the Infraorbital Hollow Area | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03777917) |
| August 28, 2018 | NCT03650387 | Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs... | Merz North America, Inc. | Not applicable | Completed | Signs of Facial Aging With Volume Loss in the Upper Cheeks, Nasolabial Folds and Marionette Lines | 207 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03650387) |
| July 11, 2018 | NCT03583359 | Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline | Merz North America, Inc. | Not applicable | Completed | Improvement of Jawline Contour | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03583359) |
| November 22, 2017 | NCT03351335 | Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients | Merz North America, Inc. | Not applicable | Completed | Mild to Moderate Skin Laxity Under the Chin, Mild to Moderate Skin Laxity on Neck | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03351335) |
| October 26, 2017 | NCT03321825 | Evaluation of the Merz Cheek Fullness Assessment Scale in the Treatment of Midface Volume Deficit | Merz North America, Inc. | Not applicable | Completed | Moderate to Severe Midface Volume Deficit | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03321825) |
| October 24, 2017 | NCT03319719 | Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds | Merz North America, Inc. | Not applicable | Completed | Correction of Moderate to Severe Nasolabial Folds | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03319719) |
| September 13, 2017 | NCT03282357 | Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China | Merz North America, Inc. | Not applicable | Completed | Correction of the Moderate to Severe Nasolabial Folds | 181 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03282357) |
| October 31, 2016 | NCT02949921 | Radiological Evaluation of Radiesse Implantation in the Hands | Merz North America, Inc. | Not applicable | Completed | Volume Loss in the Dorsum of the Hand | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02949921) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 12 |
| Phase 4 | 7 |
| Not applicable | 29 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 44 |
| Withdrawn | 3 |
| Active not recruiting | 3 |
| Terminated | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Tinea Pedis | 4 |
| Tinea Cruris | 3 |
| Tinea | 2 |
| Dermatitis, Atopic | 2 |
| Eczema | 2 |
| Dermatitis | 2 |
| Pruritus | 2 |
| Genetic Diseases, Inborn | 2 |
| Hypersensitivity | 2 |
| Hypersensitivity, Immediate | 2 |
| Immune System Diseases | 2 |
| Skin Diseases, Eczematous | 2 |
| Skin Diseases, Genetic | 2 |
| Skin Diseases | 2 |
| Exanthema | 2 |
| Mycoses | 2 |
| Cicatrix | 1 |
| Dysphonia | 1 |
| Deglutition Disorders | 1 |
| Parkinson Disease | 1 |
| Multiple Sclerosis | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Tinea Capitis | 1 |
| Cellulitis | 1 |
| Injection Site Reaction | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Escrow companies in the United States](https://specstream.ai/data/businesses/escrow-companies/united-states)
- [Home automation companies in the United States](https://specstream.ai/data/businesses/home-automation-companies/united-states)
- [Legal services firms in the United States](https://specstream.ai/data/businesses/legal-services-firms/united-states)
- [Otology practices in the United States](https://specstream.ai/data/businesses/otology-practices/united-states)
- [Rail freight companies in the United States](https://specstream.ai/data/businesses/rail-freight-companies/united-states)
- [T-shirt printers in the United States](https://specstream.ai/data/businesses/t-shirt-printers/united-states)
